Cetuximab in Treating Patients With Anal Cancer
Links shared publicly online about this topic
Cetuximab Helps Treat Colorectal Cancer:
health.msn.com — “Cetuximab Helps Treat Colorectal Cancer:” View full resource at health.msn.com
Most Recently Shared on November 25, 2009 at 5:46 pm By:
Cetuximab Helps Treat Colorectal Cancer - Drugs.com MedNews
drugs.com — “Adding the drug cetuximab to neoadjuvant chemotherapy can shrink tumors and boost the odds of successful surgery in colorectal cancer patients with inoperable m” View full resource at drugs.com
Most Recently Shared on November 25, 2009 at 9:30 pm By:
Cetuximab Helps Treat Colorectal Cancer - http://bit.ly/6NSnsP
Resectability With Cetuximab Extends Life In Difficult-to-Treat Metastatic Colorectal Cancer
medicalnewstoday.com — “Combining the epidermal growth factor receptor (EGFR) inhibitor cetuximab with conventional chemotherapy improves survival in patients who have had complete resection of colorectal liver metastase” View full resource at medicalnewstoday.com
Most Recently Shared on October 7, 2011 at 3:05 pm By:
Resectability With Cetuximab Extends Life In Difficult-to-Treat Metastatic Colorectal Cancer http://mnt.to/429C #healthnews
Combining RNA Interference With Tyrosine Kinase Inhibitors Or Cetuximab Enhances Lung Cancer Therapy
medicalnewstoday.com — “Non-small cell lung cancer (NSCLC), the most common form of lung cancer, is usually treated with surgery and chemotherapy. However, a small group of patients can also be helped by treatment with t” View full resource at medicalnewstoday.com
Most Recently Shared on March 21, 2012 at 8:05 am By:
Combining RNA Interference With Tyrosine Kinase Inhibitors Or Cetuximab Enhances Lung Cancer Therapy: Non-small ... http://t.co/nfOz9EY5
Combining Radiation Therapy, Chemotherapy Safely Treats Head And Neck Cancer Patients
medicalnewstoday.com — “Stereotactic body radiotherapy (SBRT), a radiation therapy procedure pioneered at the University of Pittsburgh Cancer Institute (UPCI) that precisely delivers a large dose of radiation to tumors,” View full resource at medicalnewstoday.com
Most Recently Shared on November 5, 2010 at 2:05 pm By:
Combining Radiation Therapy, Chemotherapy Safely Treats Head And Neck Cancer Patients http://mnt.to/3M7G #radiology
Combining radiation therapy, chemotherapy safely treats head and neck cancer patients
physorg.com — “Stereotactic body radiotherapy (SBRT), a radiation therapy procedure pioneered at the University of Pittsburgh Cancer Institute (UPCI) that precisely delivers a large dose of radiation to tumors, may effectively control and treat head and neck cancers when combined with the chemotherapy Cetuximab, according ...” View full resource at physorg.com
Most Recently Shared on November 3, 2010 at 9:07 pm By:
Combining radiation therapy, chemotherapy safely treats head and neck cancer patients http://bit.ly/ds0igI
FDA approves Erbitux to treat late-stage head and neck cancer
fda.gov — “The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.” View full resource at fda.gov
Most Recently Shared on November 7, 2011 at 7:27 pm By:
FDA approves Erbitux, in combination w/ chemotherapy, to treat late-stage head & neck cancer (release) http://t.co/bMtFRAyA
Non-AIDS-Related Cancers Growing Among HIV Patients - Drugs.com MedNews
drugs.com — “Non-AIDS-related cancers such as anal and lung cancer have become more common among HIV patients than among people without HIV since antiretroviral therapies we” View full resource at drugs.com
Most Recently Shared on September 30, 2009 at 10:17 pm By:
Non-AIDS-Related Cancers Growing Among HIV Patients - http://bit.ly/jx1X3
Colorectal cancer patients with gene mutation show better response to cancer agent
physorg.com — “Even though the cancer-treatment agent cetuximab is not considered effective treatment for KRAS (a gene)-mutated metastatic colorectal tumors, new research indicates that patients with colorectal cancer not responding to chemotherapy and a certain variation of this gene who were treated with cetuximab ...” View full resource at physorg.com
Most Recently Shared on October 26, 2010 at 9:38 pm By:
Colorectal cancer patients with gene mutation show better response to cancer agent http://bit.ly/dliF4z
Colorectal Cancer Patients with Gene Mutation Show Better Response to Cancer Agent
newswise.com — “Even though the cancer-treatment agent cetuximab is not considered effective treatment for KRAS (a gene)-mutated metastatic colorectal tumors, new research indicates that patients with colorectal cancer not responding to chemotherapy and a certain variation of this gene who were treated with cetuximab had longer overall and progression-free survival than patients with other KRAS-mutations, according to a study in the October 27 issue of JAMA.” View full resource at newswise.com
Most Recently Shared on October 26, 2010 at 8:43 pm By:
Colorectal Cancer Patients with Gene Mutation Show Better Response to Cancer Agent: Even though the cancer-treatme... http://bit.ly/aPiu2x
Data Presented From Two Phase 3 ERBITUX® Studies In First-Line Metastatic Colorectal Cancer Patients At Joint 15th European Cancer Organisation
medicalnewstoday.com — “According to a recent retrospective analysis of the pivotal Phase 3 CRYSTAL study, ERBITUX® (cetuximab), when added to FOLFIRI, was shown to increase median overall survival to 19.9 months in” View full resource at medicalnewstoday.com
Most Recently Shared on September 26, 2009 at 11:42 am By:
Data Presented From Two Phase 3 ERBITUX® Studies In First-Line Metastatic Colorectal Cancer Patients At Joint 1.. http://bit.ly/1Qiuhj
Targeted therapy that benefits patients with metastatic colon cancer fails to help patients with stage III cancer
news-medical.net — “To the surprise of researchers at Mayo Clinic who led a national clinical trial, a targeted therapy that provides benefit to patients with metastatic colon cancer has failed to help patients with less advanced, stage III cancer. In fact, patients who used the agent, cetuximab, with chemotherapy had outcomes slightly inferior to patients treated with chemotherapy alone.” View full resource at news-medical.net
Most Recently Shared on June 7, 2010 at 5:08 pm By:
Targeted therapy that benefits patients with metastatic colon cancer fails to help patients with stage III cancer:... http://bit.ly/9ie5WF
New Insights on Who Should Take Erbitux for Colon Cancer:
health.msn.com — “New Insights on Who Should Take Erbitux for Colon Cancer:” View full resource at health.msn.com
Most Recently Shared on October 26, 2010 at 8:47 pm By:
New Insights on Who Should Take Erbitux for Colon Cancer: http://on-msn.com/czELx4
New Insights on Who Should Take Erbitux for Colon Cancer - Drugs.com MedNews
drugs.com — “New research challenges previous assumptions about how to treat metastatic colon cancer in patients with a certain genetic mutation. While guidelines have recom” View full resource at drugs.com
Most Recently Shared on October 26, 2010 at 9:52 pm By:
New Insights on Who Should Take Erbitux for Colon Cancer - http://bit.ly/9rUpZw
New Insights on Who Should Take Erbitux for Colon Cancer - Drugs.com MedNews
drugs.com — “New research challenges previous assumptions about how to treat metastatic colon cancer in patients with a certain genetic mutation. While guidelines have recom” View full resource at drugs.com
Most Recently Shared on October 26, 2010 at 9:13 pm By:
New Insights on Who Should Take Erbitux for Colon Cancer: TUESDAY, Oct. 26 -- New research challenges previou... http://bit.ly/bFoWJP #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
msn
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
MNT Health News
Featured health news published by Medical News Today and chosen by the editorial team.
Advertisement

